Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRPα) in the fasted, anaesthetized rat
- 31 December 1993
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 52 (21), 1717-1726
- https://doi.org/10.1016/0024-3205(93)90480-q
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA/N-cp rats.Hypertension, 1992
- Effects of ciglitazone on endogenous plasma islet amyloid polypeptide and insulin sensitivity in obese-diabetic viable yellow miceLife Sciences, 1991
- Amylin secretion from the perfused pancreas: Dissociation from insulin and abnormal elevation in insulin-resistant diabetic ratsBiochemical and Biophysical Research Communications, 1991
- 8-37 h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivoFEBS Letters, 1991
- Amylin injection causes elevated plasma lactate and glucose in the ratFEBS Letters, 1991
- Selective antagonism of calcitonin-induced osteoclastic quiescence (Q effect) by human calcitonin gene-related peptide-(Val8Phe37)Biochemical and Biophysical Research Communications, 1991
- Amylin increases cyclic AMP formation in L6 myocytes through calcitonin gene-related peptide receptorsBiochemical and Biophysical Research Communications, 1991
- In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscleDiabetes, 1991
- The amylin superfamily: A novel grouping of biologically active polypeptides related to the insulin A-chainProgress in Growth Factor Research, 1989
- Islet amyloid polypeptide: Identification and chromosomal localization of the human geneFEBS Letters, 1988